Fundraising FoxModifi Biosciences
New Haven, US · Founded 2021 · Delaware corporation · 9 known investors
Find your way into Modifi Biosciences
Sign up to see every warm intro you have to Modifi Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Modifi Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines. It provides information for patients, investors, and communities and highlights its drug pipeline and clinical trials.
Founders & leadership
Modifi Biosciences was founded in 2021 by Ranjit Bindra and Kingson Lin.
Board
Investors · 9
How we know: Connecticut Innovations's portfolio page · funding news · press coverage · Not right? Tell us
How we know: HighCape Capital's portfolio page · funding news · biospace.com · Not right? Tell us
How we know: Pathway Bioventures's portfolio page · biospace.com · Not right? Tell us
How we know: biospace.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$15.8M disclosed across 3 rounds · 2022–2024
- $4.3Msecond round of seed financingOct 2023 · 2 sources
Advantage Capital (Ironwood), BrightEdge, Connecticut Innovation, HighCape Capital, National Brain Tumor Society, Pathway BioVentures, The Sontag Foundation
Source ↗
▶$995.5KraisedAug 2024 · 39 investors · BiotechnologyRule 506(b)
- Kat Kayser-BrickerDirector
- Kevin L. RakinExecutive Officer, Director
- Lucas de BreedDirector
- Ranjit BindraDirector
- Offering amount
- $1M
- Amount sold
- $995.5K
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$10.5MraisedAug 2023 · 40 investors · BiotechnologyRule 506(b)
- Kevin L. RakinExecutive Officer, Director
- Ranjit BindraDirector
- Lucas de BreedDirector
- Kat Kayser-BrickerDirector
- Offering amount
- $11.4M
- Amount sold
- $10.5M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Modifi Biosciences went on to found or lead other companies.
In the news
Frequently asked questions
- What does Modifi Biosciences do?
- Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines. It provides information for patients, investors, and communities and highlights its drug pipeline and clinical trials.
- Who founded Modifi Biosciences?
- Modifi Biosciences was founded by Ranjit Bindra, Kingson Lin in 2021.
- Who are Modifi Biosciences's investors?
- Modifi Biosciences's investors include Connecticut Innovations, HighCape Capital, Pathway Bioventures, Advantage Capital Partners, BrightEdge, Ironwood Capital.
- How much funding has Modifi Biosciences raised?
- Modifi Biosciences has disclosed $15.8M raised across 3 rounds.
- Where is Modifi Biosciences headquartered?
- Modifi Biosciences is headquartered in New Haven, US.